No
|
Sponsor
name
|
Sponsor
category
|
Sponsor
introduction
(100 words/
sponsor – maximum)
|
Sponsor
logo
|
1
|
Traphaco
|
Gold
sponsor
|
Traphaco Joint Stock
Company is the leading company of Vietnam’s pharmaceutical industry,
specializing in manufacturing and trading pharmaceuticals, medicinal herbs,
supplements and cosmetics, serving the needs of medical examination,
treatment, and health care of the people through medical examination and
treatment facilities, agents, and retail pharmacies nationwide.
Currently, Traphaco is
the second largest listed pharmaceutical company in terms of revenue and
profit in the pharmaceutical industry, with a strong brand name and a
nationwide distribution system. We own many best selling herbal drugs in
Vietnam; with a "win-win" business perspective, harmonizing the
interests of all parties.
During half a century
of development, Traphaco has increasingly improved the comprehensive quality
management system: GPs-WHO, ISO, ISO; Enterprises have applied more
management systems on digital platforms, gradually becoming Pharmaceutical
Enterprise 4.0: DMS software for distribution system management, ERP -
enterprise resource management, modern manufacturing technology.
|

|
2
|
Pharmagroup
|
Gold
sponsor
|
Pharma Group – the
Pharmaceutical Sector Committee of EuroCham – represents the voice of the
international research-based pharmaceutical industry in Vietnam. Pharma Group
currently has 22 members who all share the vision of ensuring patients in
Vietnam have fast and sustainable access to high quality, safe and innovative
medicines.
|

|
3
|
Novartis
|
Gold
sponsor
|
Novartis
is a global healthcare company based in Switzerland that provides solutions to address the evolving
needs of patients worldwide. Our purpose is to reimagine medicine to improve and extend
people’s lives. We deliver high-value medicines that alleviate society’s
greatest disease burdens through technology leadership in R&D and novel
access approaches. In our quest to find new medicines, we consistently rank
among the world’s top companies investing in research and development. About
103,000 people of more than 140 nationalities work together to bring Novartis
products to nearly 800 million people around the world. Find out more
at https://www.novartis.com.
|

|
4
|
Pierre
Fabre Foundation
|
Gold
sponsor
|
The mission of the Foundation
Pierre Fabre, which is a public interest organization, is to provide access
to quality medicines and care for the populations of the low and
middle-income countries (LMICs) or in emergency situations. Having
professionals trained to the highest level is a key element in the fight
against substandard or falsified medicines and in strengthening health
systems.
Since its creation in
1999, the Foundation Pierre Fabre has financed postgraduate training
(master’s, PhD) and ongoing education of many pharmacists in Africa and Asia.
After supporting master's courses in Vietnam, Laos and Cambodia between 2012
and 2019, it has committed itself from 2020 to support ongoing training in
the form of workshops and shared research projects within the Mekong Pharma
Network made up of the four universities of Hanoi (HUP), HCMC (UMP),
Vientiane (UHS) and Phnom Penh (UHS).
The Foundation Pierre
Fabre has chosen to support the organization of the "7th Conference of
the Asian Federation for Pharmaceutical Sciences" because of its
strategic importance as a place for scientific interaction and discussion for
teachers and researchers in the Mekong Pharma Network, who will be able to
meet up with and learn from their counterparts from other Asian countries and
scientists working in the pharmaceutical industry.
|

|
5
|
Astra
Zeneca
|
Silver
sponsor
|
AstraZeneca is a
global, science-led biopharmaceutical company that focuses on the discovery,
development, and commercialization of prescription medicines in Oncology,
Rare Diseases and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism,
and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca
operates in over 100 countries and its innovative
medicines are used by millions of patients worldwide.
Having accompanied
Vietnam for nearly three decades, AstraZeneca is investing into Vietnam 310
million USD from 2020 to 2030 with a focus on reducing the burdens of
non-communicable diseases, developing local talent, and uplifting the
domestic biopharmaceutical R&D and manufacturing capabilities.
|

|
6
|
Nagai
Foundation
|
Silver
sponsor
|
The Nagai Foundation
Tokyo was founded on October 25, 1986 in commemoration of Prof. Tsuneji Nagai
receiving the 1986 Hoest-Madsen Medal from FIP (International Pharmaceutical
Federation) as the first for Japanese. The Japanese Ministry of Education,
Culture, Sports, Science and Technology officially approved the Foundation as
a government-licensed international one on January 28, 1994 and additionally
as a specified non-profit organization for the benefit of the public on November
29, 1996 for the purpose of promoting international exchange in pharmacy and
pharmaceutical sciences.
|

|
7
|
Vinif
Foundation
|
Bronze
sponsor
|
Vingroup Innovation
Foundation (VINIF) was established in August 2018. For the first time, a
private foundation funded the development of science and technology of the
country in a completely non-profit way. VINIF aims towards supporting
scientists and young talents from universities and institutes to create
world-class scientific, technological and innovative researches in the field
of Science, Technology, Engineering, Medicine, Economics and Education, in
order to bring about positive and sustainable changes for Vietnam. After four
years of implementation, VINIF has sponsored and managed around 110 science,
technology and cultural history projects; Given 1.150 scholarships; Cooperate
06 training projects for Master of Data Science; Organized and sponsored
approximately 130 scientific and technological conferences, events with total
funding up to more than VND 750 billion. VINIF has built a VINIF Alumni
Club with more than 1,000 young scientists who have received VINIF
scholarships, hoping to contribute to creating a scientific research culture
with high international standards.
VINIF's sponsorship
programs include:
- Science and
Technology Project Sponsorship Program
- Cooperation and
Sponsorship for Events and Conferences
- Short-term Course
and Visiting Professor Sponsorship
- Student Scholarships
- Postgraduate
Scholarships
- Domestic
Postdoctoral Fellowship
- Sponsorship and
cooperative training
- Preserve Cultural
and Historical Values
Find out more at https://vinif.org/
|

|
8
|
GSK
|
Bronze
sponsor
|
GSK is a global
biopharma company. Our purpose is to unite science, technology and talent
to get ahead of disease together and positively impact the health of 2.5
billion people. We priorities innovation in vaccines and specialty medicines,
maximizing the increasing opportunities to prevent and treat disease... GSK
focuses on four therapeutic areas: infectious diseases, HIV, oncology, and
immunology.
GSK launched its new
legal entity in Vietnam in 2022, GSK Pharma Vietnam Company Limited,
establishing its USD 200 million investment capital in the country, aims to
growing sustainably and responsibly in Vietnam. . GSK Vietnam expressed its
commitment to continue to work together with strategic healthcare partners in
preventing and treating diseases with innovative vaccines and general
medicines, positively impact the health of more than one third of Vietnamese
population in the next three years.
|

|
9
|
MSD
|
Bronze
sponsor
|
MSD began our
operation in Vietnam through
establishing
representative offices in HCMC and
Hanoi. In 2020, MSD
decided to change its business
model from
Representative Office to Foreign
Investment Entity
(FIE) named MSD HH Vietnam Ltd.
(HH - Human Health).
The FIE is MSD’s commitment
to the Government of
Vietnam for a long-term business
presence and a solid
platform for sustainable
investment and to
patients by bringing its best and
innovative products to
them as quickly as possible.
MSD HH Vietnam works
on its aspiration to be the
most admired and
trusted healthcare partner,
delivering on MSD’s
mission of making a difference for
the people in Vietnam
through Public-private initiatives
and supports, such as:
UNFPA-MSD
Technical Collaboration
To support the
roll-out of HPV vaccination in Vietnam.
The technical
collaboration between the United Nations
Population Fund
(UNFPA) and MSD supporting the
Ministry of Health to
roll out the HPV vaccination
program in Vietnam,
with a total budget of $400,000
from 2019 to 2023.
Patient
Access Program
MSD is proud of being
the first company launching
Immuno-oncology (IO) –
a new chapter in cancer
treatment – is a
breakthrough therapy in Vietnam in
December 2017. MSD in
partnership with Bright Future
Fund (BFF) has
implemented the PAP program in 36
hospitals across
Vietnam as of end 2022. In December
2022, MSD received the
MOH Certificate of Merit for
our contribution
towards patients for having made the
most significant
contribution to Vietnamese cancer
patients – over $20
million from 2018.
|

|
10
|
Johnson & Johnson
|
Bronze
sponsor
|
At Johnson & Johnson, we believe good
health is the foundation of vibrant lives, thriving communities and forward
progress. That’s why for more than 135 years, we have aimed to keep people
well at every age and every stage of life. Today, as the world’s largest and
most diversified healthcare products company, we are committed to using our
reach and size for good. We strive to improve access and affordability,
create healthier communities, and put a healthy mind, body and environment
within reach of everyone, everywhere.
Patients inform and
inspire our science-based innovations, which continue to change and save
lives. Applying rigorous science and compassion, we confidently address some
of the most complex diseases of our time and unlock the potential medicines
of tomorrow.
Our diverse portfolio
spans multiple therapeutic areas — Oncology, Immunology, Neuroscience,
Cardiovascular, Pulmonary Hypertension, and Retina.
We are continuously
working to develop treatments, aspiring to find cures, pioneering the path
from lab to life, and championing patients every step of the way.
|

|
11
|
Boringher
|
Bronze
sponsor
|
Boehringer Ingelheim
is working on breakthrough therapies that transform lives, today and for
generations to come. As a leading research-driven biopharmaceutical company,
the company creates value through innovation in areas of high unmet medical
need.
Founded in 1885 and
family-owned ever since, Boehringer Ingelheim takes a long-term perspective.
More than 52,000 employees serve over 130 markets in the three business
areas, Human Pharma, Animal Health, and Biopharmaceutical Contract
Manufacturing.
In 2021, Boehringer
Ingelheim stepped up annual investments in R&D to a new high in history.
The company spent 4.1 billion EUR on R&D. Boehringer Ingelheim recorded
net sales of 20.6 billion EUR (2020: 19.6 billion EUR), a 5.4% increase
compared to the previous year.
Under the ‘Sustainable
Development – For Generations’ framework, Boehringer Ingelheim has globally
pledged 250 million EUR to combat infectious diseases in humans and animals
and expanding healthcare access for non-communicable diseases for 50 million
people in vulnerable communities, including in the ASKAN area. In addition to
improving across-the-board access to healthcare, Boehringer Ingelheim is
committed to carbon neutrality by 2030 and is taking bold steps to address
the growing burden of food security and safety to build a sustainable and
healthy future for all.
|

|
12
|
Eisai
Việt nam
|
Bronze
sponsor
|
Established in 1941,
Eisai is a pharmaceutical company operating globally in terms of R&D,
manufacturing, and marketing, with a strong focus on prescription medicines.
The leading philosophy of the company is “We give first thought to patients
and the people in the daily living domain, and increase the benefits that
healthcare provides to them as well as meet their diversified healthcare
needs worldwide.” With more than 10,000 employees working globally, a network
of 14 research centers (R&D) and 9 production facilities and 40
companies, Eisai is trying to realize its hhc philosophy by bringing
advanced products to meet unprocessed medical needs, especially focusing on
neurology and oncology.
|

|
13
|
LMS
Technologies Vietnam
|
Co-sponsor
|
LMS Technologies
Vietnam is under LMS Group, headquartered in Singapore and 4 ASEAN countries:
Malaysia, Thailand, Vietnam, and Indonesia.
Over 25 years of
establishment and development, we are honored to consult and support
customers in specialized laboratory equipment from R&D to QC for Material
Science.
With our desire to be
a “One-Stop Solution Provider” to our customers, we distribute a wide range
of science instruments from principals who are market leaders worldwide with
a strong reputation for quality and service support.
We are committed to
meeting the challenge of our customers’ needs for testing & analysis,
training, ISO qualifications, applications, and technical issues.
|

|
14
|
Roche
|
Co-sponsor
|
Roche: Throughout
our more than 125-year history, Roche has grown into one of the world’s
largest biotech companies, as well as a leading provider of in-vitro
diagnostics and a global supplier of transformative innovative solutions
across major disease areas. Our commitment to our people, partners,
stakeholders and, most importantly, our patients remains as strong as it was
on the first day of our journey. We are the world’s largest biotech company
with truly differentiated medicines in oncology, immunology, infectious
diseases, ophthalmology and disease of the central nervous system.
Roche is ♯1 R&D investor in healthcare. We are active in more
than 100 countries and employ more than 100,000 employees worldwide. 32 Roche
medicines on the WHO Model List of Essential Medicines. 16.4
million Patients treated with our medicines and 27 billion tests
conducted with Roche products.
Roche Pharma Vietnam
(RPV) has had an operational presence in Vietnam for almost
30 years since 1994. RPV has been collaborating with various Vietnamese
leading medical associations, healthcare organizations to empower healthcare
professionals for improved patient treatment outcomes and to enhance access
to our innovative therapies.
Our pledge to create
positive and sustainable social value goes beyond healthcare. We are
dedicated to making a lasting impact on society by building stronger and
healthier communities.
|

|
15
|
PharmaScience
|
Co-sponsor
|
Since 1983,
Pharmascience has been a leading manufacturer of generic, branded, and
over-the-counter pharmaceuticals, serving both the Canadian and international
markets. With product distribution in over 50 countries, we provide more than
1,400 different high-quality products to pharmaceutical wholesalers,
hospitals, and pharmacists. Our facilities produce more than 5 billion dosage
units of medicines every year.
A Forbes
Magazine’s 2021 “Top 300 Employer”, Pharmascience is headquartered in
Montreal, Quebec. Our 1,500 employees are committed to product quality,
R&D, and serving our communities.
|

|
16
|
Gonsa
|
Co-sponsor
|
Since its
establishmentin 2010 GONSA has been constantly developing, pursuing the
eternal goal to join hands to take care of community health. Since 2021,
GONSA has switched to the model of specializing in pharmaceutical services
with the mission: “Taking care off commuity health by providing good quality
products and certified modern GSP and GDP standard distribution services”
thereby, bringing tailored solutions to every partner’s specific requirements
with nationwide coverage, including 5 main services: Distribution Service, sale
performance through distribution channels: Hospital tenders, Hospital
pharmacies, Clinics, Retail pharmacies, Clinics with pharmacies,
Pharmaceuticals wholesale and distribution market, Storage Service with
ambient storage (below 25oC and below 30oC), cold
storage (2 to 8oC), Transport and Delivery according to GDP
standards, Authorized Import Service, Distribution Import Service and
Value-Added Services, Marketing Support Service at the site (Pharmacy): free
samples, sale display at pharmacies, clinic…
GONSA has now
successfully cooperated with more than 33,000 health facilities and
pharmacies nationwide.
GONSA – Specializing
in pharmaceutical services.
GONSA is gradually
enhancing its operational capabilities by prioritizing technological
solutions with the goal of becoming a Symbol in pharmaceutical services
quality.
Real Service – Real
Value is the enthusiasm, the business principle and also the commitment of
GONSA to customers, GONSA will always accompany with partners and customers
and offers pharmaceutical services that are unique and suitable for each
specific requirement.
|

|